Morphing the Model
Drug delivery companies hold on to technologies longer with ultimate goal of commercializing proprietary products themselves
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
March 7, 2005 Cover
Volume 83, Issue 10
Drug delivery companies hold on to technologies longer with ultimate goal of commercializing proprietary products themselves
Credit:
Drug delivery companies hold on to technologies longer with ultimate goal of commercializing proprietary products themselves
New atmospheric pressure ionization method is suitable for security and defense applications
Technique selectively encapsulates single cells and subcellular structures
A series of Japanese patent disputes raises questions about employee patent rights
Pentagon seeks ways to fund chemical weapons destruction and meet a treaty deadline
DSM Chairman Elverding reflects on completion of revamp program
Biotech executive's career experiences mirror evolution of the industry